Understanding Why Hereditary Angioedema Patients Often Do Not Carry Their On-Demand Treatment with ThemGeng B, van Kooten S, Heckmann M, Danese S, Goga L, Radojicic C
ACAAI 2023
Anxiety Associated with On-Demand Treatment of HAE Attacks May Result in Suboptimal Attack ManagementManning M, van Kooten S, Heckmann M, Danese S, Goga L, Ogbogu PU
ACAAI 2023
In Their Own Words – Patient Descriptions of the Earliest Recognition of HAE Attack OnsetManning ME, Burnette AF, van Kooten S, Heckmann M, Danese S, Goga L, Guilarte M
HAEA National Summit 2023
Recognizing the Importance of Early On-Demand Treatment in the HAE Attack JourneyJones DH, Ogbogu P, van Kooten S, Heckmann M, Danese S, Goga L, Magerl M
HAEA National Summit 2023
Preferences of People with Hereditary Angioedema for On-Demand Treatment: A US-Based Qualitative StudyBukstein DA, Vibha Desai V, Goga L, Czado S, Brown M, Myers K, Audhya PK, Settipane RA, Busse PJ
HAEA National Summit 2023
Understanding the complex decision-making associated with on-demand treatment of hereditary angioedema (HAE) attacksGrumach A, van Kooten S, Heckmann M, Danese S, Goga L, Garcez T
EAACI 2023
Remaining burden of hereditary angioedema (HAE) attacks despite modern long-term prophylaxisBetschel S, van Kooten S, Heckmann M, Danese S, Caballero T
EAACI 2023
Patients delay treating hereditary angioedema (HAE) attacks with currently available, injectable, on-demand therapies: associated with on-demand treatment of hereditary angioedema (HAE) attacksValerieva A, van Kooten S, Heckmann M, Danese S, Goga L, Longhurst H
EAACI 2023
Preferences of People with Hereditary Angioedema for On-Demand Treatment: A US-Based Qualitative StudyBukstein D, Desai V, Goga L, Brown M, Settipane RA
EAC 2023
Characterizing Attack-Related Health Utility in Hereditary AngioedemaCraig T, Cribbs KA, Czado S
ISPOR 2023